Apollo goes to court over Huntsman

The buyout firm and portfolio company Hexion have begun court proceedings in an attempt to abandon the $10.6bn purchase of chemical manufacturer Huntsman citing a material adverse effect. Yesterday, an offer of nearly $1bn from investors in order to close the transaction was declined by Hexion.